Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma-Reference-Cited by-同舟云学术

Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma

Published:2013-09-24 Issue:9 Volume:8 Page:e75449
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kim Gi Jeong,Kim Hyunki,Park Young Nyun

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Global patterns of cancer incidence and mortality rates and trends;A Jemal;Cancer Epidemiol Biomarkers Prev,2010

2. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study;ZD Goodman;Cancer,1985

3. Theise ND, Nakashima O, Park YN, Nakamura Y (2010) Combined hepatocellular-cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: International agency for research on cancer. pp. 225–227.

4. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma;Z Zhu;Int J Cancer,2010

5. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma;T Yamashita;Hepatology,2013

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review);International Journal of Oncology;2024-07-31

2. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-08-22

3. Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma;Discover Oncology;2023-05-27

4. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma;Experimental & Molecular Medicine;2023-05-01

5. Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma;Cancers;2023-04-25